Hideki Takami

4PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 29, 2026
Neoadjuvant Chemotherapy (FOLFIRINOX or Gemcitabine With Nab-Paclitaxel) for Borderline-Resectable Pancreatic Cancer: Long-Term Results of a Randomized Controlled Trial (NUPAT-01).

|Jan 21, 2026
Clinicopathological Factors on Survival after Conversion Surgery for Unresectable Locally Advanced Pancreatic Cancer: A Nationwide Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Satoshi Yasuda, Sohei Satoi, Hideki Takami

|Dec 03, 2024
Phase II Randomized Controlled Trial to Evaluate the Supportive Effect of Koujin (TJ-3020) Powder in Gemcitabine and Nab-Paclitaxel-Treated Unresectable or Recurrent Pancreatic Cancer.

Tomohisa Otsu, Hideki Takami, Suguru Yamada

|Oct 06, 2023
Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria.

Nobutake Tanaka, Hideki Takami, Masamichi Hayashi

Pageof 1

Frequent Collaborators

1 joint publications

Masamichi Hayashi

1 joint publications

Satoshi Yasuda

1 joint publications

Sohei Satoi

1 joint publications

Satoshi Hirano